Jennifer Callahan - Cingulate Warrants Corporate Controller
| CINGW Stock | USD 0.03 0 10.00% |
Executive
Jennifer Callahan is Corporate Controller of Cingulate Warrants
| Age | 53 |
| Phone | 913 942 2300 |
| Web | https://www.cingulate.com |
Jennifer Callahan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jennifer Callahan against Cingulate Warrants stock is an integral part of due diligence when investing in Cingulate Warrants. Jennifer Callahan insider activity provides valuable insight into whether Cingulate Warrants is net buyers or sellers over its current business cycle. Note, Cingulate Warrants insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cingulate Warrants'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jennifer Callahan over a week ago Acquisition by Jennifer Callahan of 22459 shares of Cingulate Warrants at 6.0 subject to Rule 16b-3 | ||
Jennifer Callahan over three months ago Acquisition by Jennifer Callahan of 3487 shares of Cingulate at 0.9798 subject to Rule 16b-3 |
Cingulate Warrants Management Efficiency
The company has return on total asset (ROA) of (1.0433) % which means that it has lost $1.0433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.7382) %, meaning that it generated substantial loss on money invested by shareholders. Cingulate Warrants' management efficiency ratios could be used to measure how well Cingulate Warrants manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | EXECUTIVE Age | ||
| Keren Pushett | NeuroSense Therapeutics Ltd | N/A | |
| Niva RussekBlum | NeuroSense Therapeutics Ltd | 45 | |
| Raul MD | Cingulate | 66 | |
| Matthew MD | Cingulate | 60 | |
| Eidan Loushi | NeuroSense Therapeutics Ltd | N/A | |
| Thomas Dalton | Cingulate | N/A | |
| Hagit Binder | NeuroSense Therapeutics Ltd | 46 | |
| Ferenc MD | NeuroSense Therapeutics Ltd | 60 | |
Management Performance
| Return On Equity | -2.74 | ||||
| Return On Asset | -1.04 |
Cingulate Warrants Leadership Team
Elected by the shareholders, the Cingulate Warrants' board of directors comprises two types of representatives: Cingulate Warrants inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate Warrants' management team and ensure that shareholders' interests are well served. Cingulate Warrants' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate Warrants' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Craig Esq, Gen VP | ||
| Dr MBA, Executive COO | ||
| Raul MD, Executive Officer | ||
| Thomas Dalton, Head Relations | ||
| Jennifer CPA, Senior CFO | ||
| Shane PharmD, CEO Board | ||
| PharmD PharmD, Principal CEO | ||
| Jennifer Callahan, Corporate Controller | ||
| Matthew MD, Executive Officer |
Cingulate Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cingulate Warrants a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.74 | ||||
| Return On Asset | -1.04 | ||||
| Number Of Shares Shorted | 7.12 K | ||||
| EBITDA | (22.95 M) | ||||
| Net Income | (23.53 K) | ||||
| Cash And Equivalents | 1.92 M | ||||
| Cash Per Share | 0.17 X | ||||
| Total Debt | 3.14 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 1.10 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cingulate Stock Analysis
When running Cingulate Warrants' price analysis, check to measure Cingulate Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate Warrants is operating at the current time. Most of Cingulate Warrants' value examination focuses on studying past and present price action to predict the probability of Cingulate Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate Warrants' price. Additionally, you may evaluate how the addition of Cingulate Warrants to your portfolios can decrease your overall portfolio volatility.